NCT06379386

Long-term Prognosis and Valve Durability of TAVR

Long-term Prognosis and Valve Durability of Transcatheter Aortic Valve Replacement for Aortic Valve Disease: a Real-world, Prospective, Single-center, Observational Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: Xijing Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.

Conditions

• Aortic Valve Stenosis and Insufficiency

Interventions

Type	Name	Description
PROCEDURE	Transcatheter aortic valve replacement	A total of 1000 consecutive patients with aortic valve disease undergoing TAVR will be enrolled. Clinical follow-up will be conducted in the periprocedural and after TAVR at 1 month, 5 years, and 10 years

Timeline

• Start date: 2016-01-01
• Primary completion: 2025-12-01
• Completion: 2030-12-01
• First posted: 2024-04-23
• Last updated: 2024-04-23

Locations

1 site across 1 country: China